Tracking every rollback, reversal, and overreach — and the path back to the America we know.
On January 20, 2025, President Trump signed Executive Order 14155 directing the withdrawal of the United States from the World Health Organization. The order initiates the process to cease U.S. participation in the WHO and discontinue financial contributions to the organization. The direct impact includes halting U.S. funding to WHO programs and ending American involvement in WHO decision-making and global health coordination mechanisms.
President Trump signed an executive order directing the FDA to accelerate review of psychedelic drugs including ibogaine for medical treatment. The order aims to speed access to psychedelic-based therapies, particularly for treating post-traumatic stress disorder in military veterans. The reform could expand availability of these treatments to Americans seeking alternative mental health interventions.
President Trump signed an executive order to accelerate research on psychedelic drugs for treating mental health disorders. The order aims to expedite clinical trials and regulatory pathways for these substances. This could expand treatment options for Americans suffering from depression, PTSD, and other mental health conditions.
The Trump administration abruptly canceled tens of millions of dollars in federal teen pregnancy prevention (TPP) grants, prompting 79 House Democrats to demand reinstatement. The action removes funding for evidence-based programs designed to reduce teen pregnancy rates across the country. Democrats warn the cancellation will harm public health outcomes and disproportionately impact underserved communities.
HHS Secretary Robert F. Kennedy Jr. ended the CDC's FoodNet program that tracked parasitic infections including cyclospora across federal agencies. The termination suspended collaborative disease surveillance managed by the CDC, USDA, and FDA. The action removes early warning systems for foodborne parasitic outbreaks, leaving public health agencies and American consumers without coordinated infection tracking.
The Trump administration issued a final rule requiring most Medicaid beneficiaries aged 19-64 to demonstrate employment, community service participation, or enrollment in work programs to maintain eligibility. The policy expands work mandates across state Medicaid programs under authority of the One Big Beautiful Bill Act. Millions of low-income Americans face potential coverage loss if unable to meet work requirements.
The Trump administration CDC issued quarantine orders confining two American passengers exposed to hantavirus to a special quarantine facility in Nebraska following exposure aboard the M/V Hondius cruise ship. The action restricts the movement and liberty of individuals based on disease exposure and represents expanded federal quarantine authority. Americans face potential involuntary confinement in federal facilities based on communicable disease exposure determinations.
Health Secretary Robert F. Kennedy Jr. signed an order to keep American cruise passenger Angela Perryman in mandatory quarantine in Nebraska despite CDC medical review recommending her release. The action overrides federal health expertise and removes an individual's liberty against medical consensus. The case exemplifies executive override of public health agency recommendations and raises questions about due process in quarantine decisions.
President Trump withdrew his nomination of Casey Means for Surgeon General and announced Dr. Nicole Saphier, a Fox News contributor and radiologist, as his replacement. This marks Trump's third nominee for the Surgeon General position. The change affects the leadership of the U.S. Public Health Service and sets the direction for federal health policy.
President Trump signed Executive Order 13948 on September 13, 2020, directing the Department of Health and Human Services to allow Medicare to pay no more for drugs than the lowest price paid in other developed countries. The order applied to a subset of Medicare Part B drugs. As of 2021, the rule was blocked by federal courts before implementation, preventing direct Medicare price changes for most drugs covered under the order.